Smartleaf Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$341K Hold
1,720
0.01% 654
2026
Q1
$378K Sell
1,720
-21
-1% -$5.23K 0.01% 601
2025
Q4
$423K Buy
1,741
+183
+12% +$46.8K 0.02% 570
2025
Q3
$422K Buy
1,558
+792
+103% +$216K 0.03% 513
2025
Q2
$195K Sell
766
-456
-37% -$109K 0.02% 588
2025
Q1
$269K Buy
1,222
+46
+4% +$10.7K 0.03% 492
2024
Q4
$270K Buy
1,176
+312
+36% +$75.1K 0.03% 459
2024
Q3
$207K Buy
864
+480
+125% +$107K 0.03% 488
2024
Q2
$73.6K Buy
384
+199
+108% +$40.4K 0.01% 649
2024
Q1
$36.3K Buy
+185
New +$33.9K 0.01% 751

Other funds holding RMD

Smartleaf Asset Management's RMD Position: Q2 2026 in Review

Smartleaf Asset Management held its ResMed (RMD) position steady in Q2 2026 at 1,720 shares worth $341K. The position accounts for 0.01% of the portfolio, ranked #654.

Smartleaf Asset Management first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $423K in Q4 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Smartleaf Asset Management held 1,720 shares of ResMed worth $341K as of Q2 2026.
  • Smartleaf Asset Management left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #654 holding.
  • Smartleaf Asset Management first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
  • Smartleaf Asset Management's ResMed position peaked at $423K in Q4 2025.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.